Co-Diagnostics Inc.
CODX | NASDAQ
$1
-$0.01 (-0.99%)
Sep 22, 2026, 11:58 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 622.49K | 3.92M | 6.81M | 34.22M | 97.89M | 74.55M |
Cost of Revenue | 222.38K | 999.12K | 4.18M | 5.48M | 11.57M | 16.59M |
Gross Profit | 400.11K | 2.92M | 2.63M | 28.74M | 86.31M | 57.96M |
Operating Income | -31.28M | -40.08M | -42.71M | -26.98M | 46.06M | 41.69M |
Interest Income | 292.93K | 1.09M | 1.16M | 704.05K | 45.63K | 97.22K |
Pretax Income | -48.51M | -37.58M | -38.11M | -18.85M | 45.64M | 42.57M |
Net Income | -46.9M | -37.64M | -35.33M | -14.24M | 36.66M | 42.48M |
Selling & General & Admin | 11.44M | 20.64M | 21.14M | 21.61M | 24.95M | 12.94M |
Research & Development | 19.14M | 20.98M | 22.96M | 17.44M | 14.96M | 3.19M |
Other Expenses | 1.11M | 1.38M | 1.23M | 16.67M | 335.36K | 138.64K |
Operating Expenses | 31.68M | 43M | 45.33M | 55.72M | 40.25M | 16.27M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 2.38M | 4.48M | 6.86M | 7.34M | 13.4M | 4.67M |
Cost & Expenses | 31.91M | 44M | 49.52M | 61.2M | 51.82M | 32.86M |
Income Tax Expense | -1.62M | 57.37K | -2.78M | -4.61M | 8.98M | 90.54K |
Shares Outstanding (Basic) | 1.33M | 1.01M | 978.22K | 1.05M | 962.49K | 890.67K |
Shares Outstanding (Diluted) | 1.33M | 1.01M | 978.22K | 1.05M | 996.79K | 933.35K |
EPS (Basic) | -35.25 | -37.20 | -36 | -13.57 | 38.10 | 1.59 |
EPS (Diluted) | -35.25 | -37.20 | -36 | -13.57 | 36.90 | 1.52 |
EBITDA | -47.41M | -36.2M | -36.88M | -10.31M | 45.97M | 41.83M |
EBIT | -48.51M | -37.58M | -38.11M | -11.59M | 45.64M | 41.69M |
Depreciation & Amortization | 1.11M | 1.38M | 1.23M | 1.28M | 335.36K | 138.64K |
Add to Watchlist
Select watchlists to add or remove CODX